CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Atara Biotherapeutics's Tangible Leverage Ratio

ATRA's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




ATRA Tangible Leverage Ratio (Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
(Sep 30 2017)
III. Quarter
Y / Y Tangible Equity Change 95.7 % 104.62 % 88.38 % -29.9 % -23.78 %
Y / Y Total Liabilities Change 52.01 % 45.79 % 220.64 % 252.81 % 66.99 %
Tangible Leverage Ratio MRQ 0.09 0.07 0.06 0.2 0.12
Overall Ranking # 145 # 137 # 119 # 392 # 241
Seq. Tangible Equity Change -10.93 % 3.03 % 146.92 % -13.64 % -6.87 %
Seq. Total Liabilities Change 7.56 % 21.6 % -23.17 % 51.28 % 3.16 %



Tangible Leverage Ratio third quarter 2018 Comment
Due to net new borrowings of 7.56%, Tangible Leverage Ratio detoriated to 0.09, above company's average Tangible Leverage Ratio.

Within Biotechnology & Drugs industry in the third quarter 2018, 17 other companies have achieved lower Tangible Leverage Ratio than Atara Biotherapeutics. While Tangible Leverage Ratio total ranking has deteriorated compare to previous quarter from 137 to 145.

Explain Tangible Leverage Ratio?
What is ATRA Market Share?
Tangible Leverage Ratio third quarter 2018 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 18
Healthcare Sector # 49
Overall Market # 145


Tangible Leverage Ratio Statistics
High Average Low
0.2 0.06 0.02
(Dec 31 2017)  




Financial Statements
Atara Biotherapeutics's Tangible Equity $ 403 Millions Visit ATRA's Balance sheet
Atara Biotherapeutics's Total Liabilities $ 36 Millions Visit ATRA's Balance sheet
Source of ATRA's Sales Visit ATRA's Sales by Geography




Companies with similar Tangible Leverage Ratio in the quarter endingSep 30 2018, within Biotechnology & Drugs Industry Tangible Leverage RatioSep 30 2018 MRQ Total LiabilitiesSep 30 2018 MRQ Tangible Equity
Nantkwest, Inc.  0.25 $ 39.555  Millions$ 160.956  Millions
Crispr Therapeutics Ag  0.24 $ 101.589  Millions$ 417.011  Millions
Syndax Pharmaceuticals Inc  0.24 $ 15.647  Millions$ 64.274  Millions
Emergent Biosolutions Inc.  0.24 $ 193.230  Millions$ 809.658  Millions
Pulse Biosciences, Inc.  0.23 $ 4.652  Millions$ 19.904  Millions
Intellia Therapeutics, Inc.  0.22 $ 57.963  Millions$ 263.270  Millions
Nymox Pharmaceutical Corporation  0.22 $ 0.849  Millions$ 3.930  Millions
Allena Pharmaceuticals, Inc.  0.20 $ 11.793  Millions$ 58.445  Millions
Fate Therapeutics Inc  0.19 $ 32.635  Millions$ 173.929  Millions
Bluebird Bio, Inc.  0.18 $ 350.999  Millions$ 1,973.553  Millions
Aptose Biosciences Inc.  0.17 $ 2.370  Millions$ 13.925  Millions
Caladrius Biosciences, Inc.  0.17 $ 6.772  Millions$ 40.809  Millions
Opiant Pharmaceuticals, Inc.  0.16 $ 4.128  Millions$ 25.155  Millions
Aerie Pharmaceuticals Inc  0.15 $ 40.612  Millions$ 268.582  Millions
Idera Pharmaceuticals, Inc.  0.14 $ 10.270  Millions$ 74.866  Millions
Protagonist Therapeutics, Inc  0.14 $ 16.928  Millions$ 123.958  Millions
Neogen Corp  0.13 $ 59.300  Millions$ 448.595  Millions
Arca Biopharma, Inc.  0.13 $ 0.982  Millions$ 7.463  Millions
Dare Bioscience, Inc.  0.13 $ 1.212  Millions$ 9.584  Millions
Jounce Therapeutics, inc.  0.12 $ 12.854  Millions$ 103.410  Millions
Adaptimmune Therapeutics Plc  0.12 $ 33.470  Millions$ 274.640  Millions
Myokardia Inc  0.12 $ 44.641  Millions$ 379.337  Millions
Infinity Pharmaceuticals, Inc.  0.10 $ 6.141  Millions$ 59.772  Millions
Proteon Therapeutics Inc  0.10 $ 2.534  Millions$ 24.871  Millions
Gtx Inc  0.10 $ 3.121  Millions$ 30.867  Millions
Novus Therapeutics, Inc.  0.10 $ 1.603  Millions$ 16.458  Millions
Foamix Pharmaceuticals Ltd.  0.10 $ 10.129  Millions$ 105.058  Millions
Audentes Therapeutics, Inc.  0.09 $ 27.218  Millions$ 298.924  Millions
Fennec Pharmaceuticals Inc.  0.09 $ 2.076  Millions$ 22.859  Millions
Atara Biotherapeutics, Inc.  0.09 $ 36.083  Millions$ 403.054  Millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CUB's Profile

Stock Price

CUB's Financials

Business Description

Fundamentals

Charts & Quotes

CUB's News

Suppliers

CUB's Competitors

Customers & Markets

Economic Indicators

CUB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071